Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial.
Esther WittermansStefan M T VestjensSimone M C SpoorenbergWillem L BlokJan C GruttersRob JanssenGer T RijkersFrank W J M SmeenkG Paul VoornEwoudt M W van de GardeWillem Jan W Bosnull nullnull nullPublished in: The European respiratory journal (2021)
Oral dexamethasone reduced LOS and ICU admission rate in adults hospitalised with CAP. It remains unclear for which patients the risk-benefit ratio is optimal.
Keyphrases
- clinical trial
- end stage renal disease
- community acquired pneumonia
- ejection fraction
- chronic kidney disease
- intensive care unit
- prognostic factors
- emergency department
- high dose
- low dose
- study protocol
- open label
- randomized controlled trial
- mechanical ventilation
- phase iii
- combination therapy
- phase ii
- acute respiratory distress syndrome